ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis

被引：0
|
作者：
Ryota Nakanishi
Eiji Oki
Hirofumi Hasuda
Eiki Sano
Yu Miyashita
Akihiro Sakai
Naomichi Koga
Naotaka Kuriyama
Kentaro Nonaka
Yoshiaki Fujimoto
Tomoko Jogo
Kentaro Hokonohara
Qingjiang Hu
Yuichi Hisamatsu
Koji Ando
Yasue Kimura
Tomoharu Yoshizumi
Masaki Mori
机构：
[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2986 / 2987
页数：1
相关论文
共 50 条
  • [21] Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy
    Gerger, A.
    Zhang, W.
    Yang, D.
    Bohanes, P. O.
    Ning, Y.
    Winder, T.
    Labonte, M. J.
    Wilson, P. M.
    Benhaim, L.
    El-Khoueiry, R.
    Absenger, G.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    Baba, H.
    Watanabe, M.
    Okabe, H.
    Miyamoto, Y.
    Sakamoto, Y.
    Baba, Y.
    Iwatsuki, M.
    Chikamoto, A.
    Beppu, T.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 1950 - 1955
  • [23] Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
    Saltz, Leonard B.
    Clarke, Stephen
    Diaz-Rubio, Eduardo
    Scheithauer, Werner
    Figer, Arie
    Wong, Ralph
    Koski, Sheryl
    Lichinitser, Mikhail
    Yang, Tsai-Shen
    Rivera, Fernando
    Couture, Felix
    Sirzen, Florin
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2013 - 2019
  • [24] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    H Baba
    M Watanabe
    H Okabe
    Y Miyamoto
    Y Sakamoto
    Y Baba
    M Iwatsuki
    A Chikamoto
    T Beppu
    British Journal of Cancer, 2012, 107 : 1950 - 1955
  • [25] Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer
    Sorbye, Halfdan
    Berglund, Ake
    Tveit, Kjell Magne
    Ogreid, Dagfinn
    Wanderas, Eva Hoff
    Wentzel-Larsen, Tore
    Dahl, Olav
    Glimelius, Bengt
    ACTA ONCOLOGICA, 2007, 46 (07) : 982 - 988
  • [26] TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy
    Matsusaka, Satoshi
    Zhang, Wu
    Cao, Shu
    Hanna, Diana L.
    Sunakawa, Yu
    Sebio, Ana
    Ueno, Masashi
    Yang, Dongyun
    Ning, Yan
    Parekh, Anish
    Okazaki, Satoshi
    Berger, Martin D.
    Ichikawa, Wataru
    Mizunuma, Nobuyuki
    Lenz, Heinz-Josef
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (06) : 1405 - 1411
  • [27] Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer
    Liu, Zhuo
    Kong, Jiangyin
    Kong, Yuanyuan
    Cai, Feng
    Xu, Xiaocheng
    Liu, Jun
    Wang, Shihua
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (11): : 1459 - 1468
  • [28] Multiple Liver Lesions After Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Shlomai, Amir
    Tobar, Ana
    Benjaminov, Ofer
    GASTROENTEROLOGY, 2015, 149 (06) : E1 - E3
  • [29] Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis
    Park, Hanla A.
    Edelmann, Dominic
    Canzian, Federico
    Harrison, Tabitha A.
    Hua, Xinwei
    Shi, Qian
    Silverman, Allison
    Schneider, Martin
    Goldberg, Richard M.
    Alberts, Steven R.
    Hoffmeister, Michael
    Brenner, Hermann
    Chan, Andrew T.
    Peters, Ulrike
    Newcomb, Polly A.
    Chang-Claude, Jenny
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (11) : 2087 - 2091
  • [30] First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial
    Ree, Anne Hansen
    Benth, Jurate Saltyte
    Hamre, Hanne M.
    Kersten, Christian
    Hofsli, Eva
    Guren, Marianne G.
    Sorbye, Halfdan
    Johansen, Christin
    Negard, Anne
    Bjornetro, Tonje
    Nilsen, Hilde L.
    Berg, Jens P.
    Flatmark, Kjersti
    Meltzer, Sebastian
    BRITISH JOURNAL OF CANCER, 2024, 130 (12) : 1921 - 1928
12345